News
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

693,921 Results

Type

Article (41287)
Company Profile (224)
Press Release (652410)

Section

Business (209099)
Career Advice (2040)
Deals (36542)
Drug Delivery (85)
Drug Development (82439)
Employer Resources (170)
FDA (16312)
Job Trends (15304)
News (353513)
Policy (33755)

Tag

Date

Today (45)
Last 7 days (499)
Last 30 days (1924)
Last 365 days (38851)
2024 (21951)
2023 (40630)
2022 (51799)
2021 (56337)
2020 (54795)
2019 (47404)
2018 (35777)
2017 (33143)
2016 (32667)
2015 (38622)
2014 (32518)
2013 (27635)
2012 (29732)
2011 (30489)
2010 (28502)

Filters

Type

Article (41287)
Company Profile (224)
Press Release (652410)

Section

Business (209099)
Career Advice (2040)
Deals (36542)
Drug Delivery (85)
Drug Development (82439)
Employer Resources (170)
FDA (16312)
Job Trends (15304)
News (353513)
Policy (33755)

Tag

Date

Today (45)
Last 7 days (499)
Last 30 days (1924)
Last 365 days (38851)
2024 (21951)
2023 (40630)
2022 (51799)
2021 (56337)
2020 (54795)
2019 (47404)
2018 (35777)
2017 (33143)
2016 (32667)
2015 (38622)
2014 (32518)
2013 (27635)
2012 (29732)
2011 (30489)
2010 (28502)

693,921 Results for "teva pharmaceuticals inc".

Sort By

Pharm Country

Teva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States

Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of an authorized generic of Victoza®1 (liraglutide injection 1.8mg), in the United States.

June 24, 2024
·
9 min read
Policy

UroGen Pharma Files Patent Infringement Action Against Teva Pharmaceuticals

UroGen Pharma Ltd. today announced that it has filed a lawsuit in the U.S. District Court for the District of Delaware against Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc., and Teva Pharmaceutical Industries, Ltd., alleging infringement of U.S. Patent Numbers 9,040,074 (“the ’074 patent”) and 9,950,069.

April 3, 2024
·
9 min read
Policy

Teva Loses Inhaler Patent Case Against Amneal, Must Delete or Amend Orange Book Listing

Teva Pharmaceuticals lost its patent row with Amneal Pharmaceuticals on Monday as a New Jersey court ruled that some of Teva’s claims over its inhaler product ProAir HFA were improperly listed on the FDA’s Orange Book.

June 12, 2024
·
2 min read
·
Tristan Manalac
Business

Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations

Teva Pharmaceutical Industries Ltd. today announced the appointment of Matthew Shields as Executive Vice President of Teva Global Operations (TGO), the Company’s manufacturing and supply division, effective June 3, 2024.

May 15, 2024
·
7 min read
Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva’s President and CEO, will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024.

June 4, 2024
·
2 min read
Policy

FTC Investigates Teva Over Refusal to Remove Improperly Listed Patents from Orange Book

The Federal Trade Commission has opened an investigation into Teva Pharmaceuticals after the company allegedly ignored directives to withdraw or amend contentious patent listings on the FDA’s Orange Book.

July 2, 2024
·
1 min read
·
Tristan Manalac
Policy

Teva Pays $750M to Resolve Israeli Tax Issues Going Back More Than a Decade

Teva Pharmaceuticals has settled years of tax litigation with the Israel Tax Authority for $750 million, which the company will pay in installments starting in 2024 to 2029.

June 26, 2024
·
2 min read
·
Tristan Manalac
Genetown

Clinical Collaboration Agreement between Teva and Launch Therapeutics to Accelerate Development of Dual-Action Asthma Rescue Inhaler (ICS-SABA/TEV-’248) Respiratory Program; Teva and Abingworth Enter Strategic Development Funding Agreement

Teva Pharmaceutical Industries Ltd. and Launch Therapeutics, Inc., announced a clinical collaboration agreement to further accelerate the clinical research program of Teva’s ICS-SABA.

April 1, 2024
·
9 min read
Teva to Present at the 2024 Bank of America Healthcare Conference

Teva Pharmaceutical Industries Ltd. announced that Richard Francis, Teva’s President and CEO, will present at the 2024 Bank of America Healthcare Conference on Tuesday, May 14, 2024.

May 2, 2024
·
2 min read
Pharm Country

Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., announced new patient- and physician-reported interim results from the Phase 4 IMPACT-TD Registry study, reinforcing that TD has a wide-reaching, multidimensional impact on patients’ quality of life.

June 1, 2024
·
12 min read

1 of 69,393

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
Hotbeds
About
More

© 1985 - 2024 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin